Literature DB >> 3524658

Immunohistochemical study of basement membrane proteins and type III procollagen in myelofibrosis.

M Apaja-Sarkkinen, H Autio-Harmainen, M Alavaikko, J Risteli, L Risteli.   

Abstract

In this study the distribution of type IV collagen in the marrow is compared with that of laminin, another basement membrane protein. In addition, incompletely processed type III procollagen is identified with specific antibodies. In normal bone marrow the distribution of the type III procollagen antigen closely resembles that of reticulin staining. In all the myelofibrotic samples, representing both early and advanced disease, the fibrous tissue stains heavily for this antigen. Thus type III procollagen which has not completely lost its aminoterminal propeptide is a genuine component of the extracellular matrix fibres in human bone marrow. Laminin is found with type IV collagen in continuous basement membranes in arterial walls, whereas only discontinuous strips of staining are seen along the sinusoids in normal marrow. In myelofibrosis the dilated or obliterated sinusoids have thickened or continuous basement membranes, visible with both stainings. Neovascularization also increases the extent of basement membrane staining in fibrotic marrow. With respect of these antigens, there is no difference between primary and secondary myelofibrosis. These changes warrant the use of serum antigens related to type IV collagen and to type III procollagen as markers for developing myelofibrosis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3524658     DOI: 10.1111/j.1365-2141.1986.tb07535.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  7 in total

Review 1.  Pathogenesis of idiopathic myelofibrosis: role of growth factors.

Authors:  J T Reilly
Journal:  J Clin Pathol       Date:  1992-06       Impact factor: 3.411

2.  Type I collagen as a marker of bone metabolism in sickle cell hemoglobinopathies.

Authors:  D M Bolarin; P Swerdlow; A M Wallace; L Littsey
Journal:  J Natl Med Assoc       Date:  1998-01       Impact factor: 1.798

Review 3.  The pathogenesis of chronic myeloproliferative diseases.

Authors:  A Tefferi
Journal:  Int J Hematol       Date:  2001-02       Impact factor: 2.490

4.  Tenascin immunoreactivity in normal and pathological bone marrow.

Authors:  Y Soini; D Kamel; M Apaja-Sarkkinen; I Virtanen; V P Lehto
Journal:  J Clin Pathol       Date:  1993-03       Impact factor: 3.411

5.  TGF-beta1 induces bone marrow reticulin fibrosis in hairy cell leukemia.

Authors:  Medhat Shehata; Josef D Schwarzmeier; Martin Hilgarth; Rainer Hubmann; Markus Duechler; Heinz Gisslinger
Journal:  J Clin Invest       Date:  2004-03       Impact factor: 14.808

6.  Type III collagen regulates osteoblastogenesis and the quantity of trabecular bone.

Authors:  Susan W Volk; Shalin R Shah; Arthur J Cohen; Yanjian Wang; Becky K Brisson; Laurie K Vogel; Kurt D Hankenson; Sherrill L Adams
Journal:  Calcif Tissue Int       Date:  2014-03-14       Impact factor: 4.333

7.  Serum Biomarkers for Connective Tissue and Basement Membrane Remodeling are Associated with Vertebral Endplate Bone Marrow Lesions as Seen on MRI (Modic Changes).

Authors:  Stefan Dudli; Alexander Ballatori; Anne-Christine Bay-Jensen; Zachary L McCormick; Conor W O'Neill; Sibel Demir-Deviren; Roland Krug; Irina Heggli; Astrid Juengel; Jaro Karppinen; Florian Brunner; Mazda Farshad; Oliver Distler; Jeffrey C Lotz; Aaron J Fields
Journal:  Int J Mol Sci       Date:  2020-05-27       Impact factor: 6.208

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.